Financial Coaching and Smoking Cessation Study

This study is testing if combining financial counseling with standard smoking cessation counseling is more effective at helping people quit smoking long-term. You would receive either standard smoking cessation counseling or counseling that also includes financial guidance. Both groups will receive nicotine replacement therapy (patches, lozenges, or gum) for 8 weeks. Researchers will measure your smoking abstinence (how long you've stopped smoking) after 12 months using saliva and breath tests. To join, you must be an adult (18-100 years old), smoke at least 5 cigarettes daily, be interested in both types of counseling, have an income below 200% of the federal poverty level, live in New York City, and speak English or Spanish. The study aims to enroll 602 participants, but the current status is unclear.

Study design
This is a randomized controlled trial with two groups. You would be randomly assigned to one of the two groups, and a total of 900 participants are planned.
What's involved
You would receive 8 weeks of nicotine replacement therapy. You will also complete surveys at the beginning of the study, at 6 months, and at 12 months.
Compensation
Not stated in the trial record.
Follow-up
Your smoking abstinence will be checked at 12 months after the study begins.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05154669

Integrating Financial Coaching and Smoking Cessation Coaching

Recruiting
PHASE3Ages 18+InterventionalTreatment
NYU Langone Health
~602 participants
Updated 2026-05-04 on ClinicalTrials.gov
What's tested:Financial counselingNicotine Replacement Therapy Agent - PatchesNicotine Replacement Therapy Agent - LozengesNicotine Replacement Therapy Agent - Gum

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Effectiveness of the integrated intervention to standard cessation counseling on long-term abstinence (salivary cotinine)
Measured over 12 months
+1 more outcome measured
Smoking
1 sites across 1 states
New York1
  • Erin Rogers, DrPH · PRINCIPAL_INVESTIGATOR · NYU Langone Health

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

age ≥18 years,
smokes ≥5 cigarettes per day,
interested in receiving smoking and financial counseling,
self-reported income below 200% of the current federal poverty level,
New York City resident,
speaks English or Spanish language (the interventions and measures have not been validated in other languages),
able to provide informed consent, and
does not have a representative who manages his/her funds.

Exclusion

people who know a current past study participant (to avoid intervention contamination)
People who have a medical contraindication to using nicotine replacement therapy:
allergy to nicotine patch
pregnancy or intention to become pregnant over the next 12 months
breastfeeding
heart attack in the past 2 months
underlying arrhythmia
ongoing or worsening angina.
  • Effectiveness of the integrated intervention to standard cessation counseling on long-term abstinence (salivary cotinine)12 months

    The study will collect salivary cotinine from participants reporting 7-day abstinence from cigarettes on the 12-month survey. The study will use a saliva collection kit supplied by Salimetrics Inc. Participants will be classified as negative for salivary cotinine if their concentration is \<10ng/ml,

  • Effectiveness of the integrated intervention to standard cessation counseling on long-term abstinence (CO concentration)12 months

    The study will collect exhaled CO from participants reporting 7-day abstinence from cigarettes on the 12-month survey. The study will use a coVita Co monitor that provides an immediate CO concentration reading in single parts per million (ppm). Participants will be classified as negative for exhaled CO if their concentration is \<8 ppm.